Alkylating agentPopulation PK (2-CMT parent + 1-CMT metabolite)IV infusionNephrology

Population PK model of oral cyclophosphamide

Indication: Autoimmune glomerulonephritis remission induction

Interactive IV cyclophosphamide population PK simulator for autoimmune glomerulonephritis remission induction. Models parent cyclophosphamide and active 4-hydroxycyclophosphamide exposure from a published parent-metabolite model for this DNA-alkylating prodrug.

Drug Overview

Clinical Context

Molecular Target
DNA alkylation via phosphoramide mustard (cyclophosphamide prodrug)
Drug Class
Alkylating agent
Therapeutic Area
Nephrology
Indication
Autoimmune glomerulonephritis remission induction
Route of Administration
IV infusion

Model Information

Model Type
Population PK (2-CMT parent + 1-CMT metabolite)

This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.

About This Simulator

This interactive pharmacokinetic simulator for Population allows you to explore concentration-time profiles under different dosing scenarios. The underlying Population PK (2-CMT parent + 1-CMT metabolite) model characterizes the pharmacokinetics of this alkylating agent following iv infusion administration.

Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).

Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.

Frequently Asked Questions

What is the Population PK simulator?

This is a free, interactive pharmacokinetic simulator for Population used in Autoimmune glomerulonephritis remission induction. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.

What drug class does Population belong to?

Population is classified as a Alkylating agent that targets DNA alkylation via phosphoramide mustard (cyclophosphamide prodrug). It is used in the Nephrology therapeutic area.

What route of administration does this model simulate?

This simulator models IV infusion administration of Population. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.

What type of PK model is used?

This simulator uses a Population PK (2-CMT parent + 1-CMT metabolite) model. This model characterizes the time-course of drug concentrations following dosing.

Is this simulator free to use?

Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.

Can I use this for clinical dosing decisions?

No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.

Related Simulators

Ready to Simulate?

Launch the Population simulator to explore dosing scenarios and pharmacokinetic profiles interactively.

🚀 Launch Simulator

Comments

0/2000
Loading comments...

⚠️ Disclaimer

This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.

Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community